Sanctuary Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Buy
7,424
+813
+12% +$69.1K ﹤0.01% 1860
2026
Q1
$570K Buy
6,611
+151
+2% +$13.6K ﹤0.01% 1698
2025
Q4
$564K Sell
6,460
-2,828
-30% -$215K ﹤0.01% 1654
2025
Q3
$532K Sell
9,288
-3,202
-26% -$184K ﹤0.01% 1676
2025
Q2
$737K Buy
12,490
+971
+8% +$62.7K ﹤0.01% 1394
2025
Q1
$843K Buy
11,519
+250
+2% +$20.7K 0.01% 1216
2024
Q4
$1.05M Sell
11,269
-676
-6% -$53.3K 0.01% 1231
2024
Q3
$1.01M Buy
11,945
+3,022
+34% +$213K 0.01% 1243
2024
Q2
$451K Buy
+8,923
New +$533K ﹤0.01% 1717

Other funds holding GMED

Sanctuary Advisors's GMED Position: Q2 2026 in Review

Sanctuary Advisors increased its Globus Medical (GMED) stake by 12% in Q2 2026, buying an estimated $69.1K and bringing the position to 7,424 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Sanctuary Advisors first reported a position in GMED in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.05M in Q4 2024. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Sanctuary Advisors held 7,424 shares of Globus Medical worth $587K as of Q2 2026.
  • Sanctuary Advisors bought 813 Globus Medical shares in Q2 2026, an estimated $69.1K.
  • Globus Medical made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1860 holding.
  • Sanctuary Advisors first reported a position in Globus Medical in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Globus Medical position peaked at $1.05M in Q4 2024.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.